D., & Sadovsky, R
These plaintiffs say GLP-1 drugs led them to be diagnosed with gastric disorders, liver and pancreatic injuries, bowel conditions, or other injuries
This may lead to insulin resistance, weight gain, obesity, and type 2 diabetes
doi: 10.1016/j.nut.2011.08.013 228 MartarelliDVerdenelliMCScuriSCocchioniMSilviSCecchiniCet al
Related Reading Temporary Glp 1 Provider While Prior Authorization Pending Plexusdx Semaglutide Providers That Take Fsa Plexusdx How Much Calcium Should Women Consume Daily For Optimal Bone Health Do You Consume Enough Folate To Maintain Your Health Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Mounjaro is the newest advancement in GLP-1 therapies, combining GLP-1 and GIP receptor agonists for increased weight loss effects all while minimizing side effects